José Gómez-García

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia

Carolina Moreno, Marco Montillo, Panayiotis Panayiotidis et al. · Haematologica · 2015 · 40 citations · Full text

Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non–small cell lung cancer

Ahmad A. Tarhini, Imran Rafique, Theofanis Floros et al. · Cancer · 2017 · 39 citations · Full text

Programmable Fusion and Differentiation of Synthetic Minimal Cells

Nathaniel J. Gaut, José Gómez-García, Joseph M. Heili et al. · ACS Synthetic Biology · 2022 · 35 citations

Live Artificial Cells, Engineering, Molecular Biology +24

Real-Time Visualization of <i>in Vitro</i> Transcription of a Fluorescent RNA Aptamer: An Experiment for the Upper-Division Undergraduate or First-Year Graduate Laboratory

Joseph M. Heili, José Gómez-García, Nathaniel J. Gaut et al. · Journal of Chemical Education · 2018 · 19 citations

Real-time Visualization, Engineering, Molecular Biology +23

Controlled exchange of protein and nucleic acid signals from and between synthetic minimal cells

Joseph M. Heili, Kaitlin Stokes, Nathaniel J. Gaut et al. · Cell Systems · 2024 · 12 citations